Open Access

Audience Q&A.

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
sponsored by Bayer AG

Congress Session

5 more presentations in this session

Welcome and introduction.

Speaker: Professor C. Lam (Singapore, SG)


What if... your patient has experienced a worsening HF event?

Speaker: Professor F. Ruschitzka (Zurich, CH)


What if... you have decided to prescribe vericiguat for your patient?

Speaker: Professor B. Pieske (Berlin, DE)


What if... your patient is unable to tolerate existing HFrEF therapies?

Speaker: Doctor S. Zieroth (Winnipeg, CA)


Closing remarks.

Speaker: Professor C. Lam (Singapore, SG)


Access the full session

Time to act: what if your patient is in need of a different strategy following a worsening heart failure event?

Speakers: Professor C. Lam, Professor F. Ruschitzka, Professor B. Pieske, Doctor S. Zieroth, Professor C. Lam

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk